Opko Health, Inc.OPK

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$1.64
Market cap
$1.2B
P/E
—
Revenue (TTM)
$587.9M
Net income
-$72.9M
Dividend yield
—
1-year total return
14.7%
Net margin
-12.4%
Revenue growth
-11.5%
Debt / equity
0.00x

What Opko Health, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$1.4B$1.8B$1.0B$863.5M$713.1M$606.9M
Net income$30.6M-$30.1M-$328.4M-$188.9M-$53.2M-$225.7M
Free cash flow$5.8M$6.2M-$119.8M-$44.5M-$208.5M-$190.8M

More on OPK.

Figures from Opko Health, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.